IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells.
Gambardella AR, Antonucci C, Zanetti C, Noto F, Andreone S, Vacca D, Pellerito V, Sicignano C, Parrottino G, Tirelli V, Tinari A, Falchi M, De Ninno A, Businaro L, Loffredo S, Varricchi G, Tripodo C, Afferni C, Parolini I, Mattei F, Schiavoni G.
Gambardella AR, et al. Among authors: antonucci c.
J Exp Clin Cancer Res. 2024 Jul 27;43(1):209. doi: 10.1186/s13046-024-03129-1.
J Exp Clin Cancer Res. 2024.
PMID: 39061080
Free PMC article.